Benchmark Electronics, Inc. (BHE) Stock Price & How to Invest

Benchmark Electronics (NYSE: BHE), headquartered in Tempe, Arizona and founded in 1979, is a global electronics manufacturing services (EMS) provider. It offers full product-lifecycle solutions, from design and engineering through prototyping, high-complexity printed circuit board assembly, system integration, and aftermarket support. The company deliberately targets low-to-medium volume, high-mix, high-reliability work in regulated end markets, including aerospace and defense (AC&C), medical technologies, semiconductor capital equipment, complex industrials, and next-generation communications. It operates roughly 22 sites across about eight countries with around 12,000 employees.

The investment picture is one of a cyclical manufacturer trying to move up the value chain. Revenue is in the mid-$2 billion range annually, and recent results show renewed growth led by semi-cap, medical, and defense demand alongside reshoring of supply chains. Gross margins sit in the low double digits, which is structurally thin, so the story hinges on mix shift toward complex engineering-led programs, disciplined cost control, and free-cash-flow generation. As a smaller peer to giants like Jabil and Flex, BHE competes on specialization and certifications rather than scale, which supports differentiation but also concentrates risk in a handful of large customer programs.

EMS is a structurally low-margin, capital-intensive, and cyclical business, so gross margins near the low double digits leave limited buffer against demand slowdowns or pricing pressure. Benchmark is smaller than scale players like Jabil and Flex, which can bid aggressively on volume work, and revenue is concentrated in a relatively small number of large customer programs that can be won or lost. End markets such as semiconductor capital equipment are highly cyclical, and any pullback in AI-related or chip capital spending could pressure results. The valuation has expanded on the growth narrative, so any margin compression or guidance miss could weigh on the shares. Broader macro, tariff, and component-supply risks also affect manufacturing throughput.

3 analysts publish price targets on BHE, averaging $86.00 against a $70.48 price as of September 2026, or +22.0%. The published targets run from $76.00 to $92.00, a narrow spread, and the ratings split 2 buy, 1 hold, 0 sell. Over the last six months there have been 2 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BHE forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Benchmark Electronics, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Aerospace, defense, and reshoring demand. Elevated global defense budgets and supply-chain reshoring favor domestic, security-cleared manufacturing partners. The most optimistic published target, $92.00, assumes this works close to its best case.

The case against. EMS is a structurally low-margin, capital-intensive, and cyclical business, so gross margins near the low double digits leave limited buffer against demand slowdowns or pricing pressure. The most pessimistic target, $76.00, is roughly what BHE is worth if this bites instead.

Read the full bull and bear case on BHE, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Benchmark Electronics, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$2.7B
• Q1 2026 revenue: ~$677M (up ~7% YoY)
• Market cap: ~$3.0B
• Non-GAAP EPS (Q1 2026): ~$0.58
• Dividend (annualized): ~$0.68 (~0.8% yield)
• FY2026 revenue growth outlook: ~9-10%

Benchmark trades at a valuation that has expanded alongside its improving margins and defense and medical growth, leaving its price-to-earnings multiple elevated relative to the traditionally low-multiple EMS group. As a thin-margin manufacturer, its earnings can swing with mix and utilization, so free-cash-flow generation and the raised full-year outlook matter as much as the reported multiple.

Other names that sit close to BHE: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BHE exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BHE sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BHE fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BHE is a specialized, engineering-heavy EMS operator whose appeal rests on defense and medical demand plus margin expansion, tempered by thin manufacturing margins and program-level customer concentration.

Whether BHE is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BHE a buy or a sell?, and where the stock could go from here in the BHE stock forecast.

For income investors, whether BHE pays a dividend and how the payout looks is covered in does BHE pay a dividend? And to weigh BHE against a peer, read the full side-by-side comparisons: BHE vs FLEX and BHE vs CLS.